Brief: Oncolytics Biotech Reports Q4 Loss Per Share Of C$0.14
03/03/2023 12:16
March 3 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH INC Q4 LOSS PER SHARE C$0.14
* ONCOLYTICS BIOTECH® REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
* ONCOLYTICS BIOTECH INC - PROVIDES PROJECTED RUNWAY THROUGH
BRACELET-1'S UPCOMING READOUT AND INTO 2024
* ONCOLYTICS BIOTECH - $32.1 MILLION IN CASH, CASH
EQUIVALENTS &
MARKETABLE SECURITIES AS OF DEC 31, 2022 PROVIDES RUNWAY INTO
2024
Source text for Eikon: ID:nPn1YqhXka
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer